Sanjeev Menon
Head of Partnerships, Ubie
Sanjeev Menonsecurehost2025-04-04T14:27:46+00:00
APRIL 2025
In this DHCG Disruptive Dose, Mark Bard of the DHC Group and Sanjeev Menon, Head of Partnerships at Ubie explore the evolving role of AI in healthcare—particularly the growing impact of clinically focused large language models. Sanjeev shares insights from Ubie’s work with 1,900 provider organizations, where their AI-driven solutions have improved diagnostic accuracy and significantly reduced time spent gathering information. The conversation touches on the balance between AI and human oversight, the importance of transparency and trust signals for patient adoption, and the need for pharma to tread carefully when introducing branded tools. Sanjeev also highlights how regulatory compliance, real-world data, and collaboration across stakeholders will be key to unlocking AI’s full potential as a trusted extension of the care team.